Cubist Systematic Strategies, LLC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 183 filers reported holding CARA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$102,683
-80.3%
61,121
-66.9%
0.00%
-66.7%
Q2 2023$522,429
-79.4%
184,604
-33.6%
0.00%
-81.2%
Q2 2022$2,537,000
+6756.8%
277,887
+9107.7%
0.02%
Q1 2022$37,000
-97.2%
3,018
-97.2%
0.00%
-100.0%
Q4 2021$1,329,000
+358.3%
109,085
+481.7%
0.01%
+225.0%
Q3 2021$290,000
-76.2%
18,753
-66.6%
0.00%
-75.0%
Q1 2021$1,218,000
+96.8%
56,115
+37.1%
0.02%
+77.8%
Q4 2020$619,000
-29.7%
40,939
-40.9%
0.01%
-30.8%
Q3 2020$881,000
+4.9%
69,226
+40.9%
0.01%
-13.3%
Q2 2020$840,000
+517.6%
49,115
+376.4%
0.02%
+275.0%
Q1 2020$136,000
-85.5%
10,310
-82.3%
0.00%
-76.5%
Q4 2019$938,000
+304.3%
58,235
+358.5%
0.02%
+240.0%
Q3 2019$232,000
+465.9%
12,700
+503.3%
0.01%
+400.0%
Q1 2019$41,000
-92.1%
2,105
-94.7%
0.00%
-96.0%
Q4 2018$521,000
+2642.1%
40,047
+1905.4%
0.02%
+1150.0%
Q4 2016$19,000
+850.0%
1,997
+634.2%
0.00%
Q3 2016$2,000
-92.9%
272
-83.4%
0.00%
-100.0%
Q4 2015$28,000
-87.6%
1,640
-89.6%
0.00%
-81.8%
Q3 2015$226,00015,8200.01%
Other shareholders
CARA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 2,799,058$42,350,00022.29%
Chescapmanager LLC 1,314,603$19,890,0002.42%
Prosight Management, LP 294,041$4,449,0002.06%
DAFNA Capital Management LLC 261,442$3,956,0001.18%
Cypress Capital Management LLC (WY) 81,269$1,230,0001.06%
KINGDON CAPITAL MANAGEMENT, L.L.C. 626,583$9,480,0001.02%
Carmignac Gestion 1,851,443$28,012,0000.29%
FARALLON CAPITAL MANAGEMENT LLC 2,465,000$37,295,0000.22%
Ikarian Capital, LLC 301,700$4,565,0000.20%
DISCIPLINED GROWTH INVESTORS INC /MN 689,899$10,438,0000.20%
View complete list of CARA THERAPEUTICS INC shareholders